SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2015 |
Dec. 31, 2014 |
Dec. 31, 2013 |
|
| Other current liabilities: | |||
| Director fees | $ 25 | $ 11 | |
| Trade payables | 41 | 29 | |
| Accrued expenses and other | 160 | 144 | |
| Other current liabilities | 226 | 184 | |
| Financial expenses: | |||
| Loss from change in fair value of investment in BioCancell and sale of BioCancell shares | (36) | (245) | |
| Other | (2) | (7) | |
| Financial expenses | $ (38) | $ (252) | |
| Financial income: | |||
| Income from change in fair value of investment in BioCancell and sale of BioCancell shares | $ 574 | ||
| Other | $ 9 | $ 12 | 5 |
| Financial income | 9 | 12 | 579 |
| Financial income (expenses), net | $ (29) | $ (240) | $ 579 |